Radiotherapy-induced overexpression of exosomal miRNA-378a-3p in cancer cells limits natural killer cells cytotoxicity

Epigenomics. 2020 Mar;12(5):397-408. doi: 10.2217/epi-2019-0193. Epub 2020 Apr 8.

Abstract

Aim: We here hypothesized that tumor-derived exosomal miRNA (TexomiR) released from irradiated tumors may play a role in the tumor cells escape to natural killer (NK) cells. Materials & methods: Our study included the use of different cancer cell lines, blood biopsies of xenograph mice model and patients treated with radiotherapy. Results: The irradiation of cancer cells promotes the TET2-mediated demethylation of miR-378 promoter, miR-378a-3p overexpression and its loading in exosomes, inducing the decrease of granzyme-B (GZMB) secretion by NK cells. An inverse correlation between TexomiR-378a-3p and GZMB was observed in murine and human blood samples. Conclusion: Our work identifies TexomiR-378a-3p as a molecular signature associated with the loss of NK cells cytotoxicity via the decrease of GZMB expression upon radiotherapy.

Keywords: DNA methylation; NK cells; TET2; exosomal miRNA; glioblastoma; granzyme B; immune response; miR-378; radiotherapy; resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cytotoxicity, Immunologic / genetics
  • Cytotoxicity, Immunologic / radiation effects
  • DNA Methylation
  • DNA-Binding Proteins / metabolism
  • Dioxygenases
  • Exosomes / metabolism*
  • Gene Expression
  • Gene Expression Regulation, Neoplastic / radiation effects*
  • Granzymes / metabolism
  • Humans
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism*
  • Mice
  • MicroRNAs / genetics*
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins / metabolism
  • Radiotherapy

Substances

  • DNA-Binding Proteins
  • MicroRNAs
  • Proto-Oncogene Proteins
  • Dioxygenases
  • TET2 protein, human
  • GZMB protein, human
  • Granzymes